| アブストラクト | Small interfering RNA (siRNA)-based medications offer the ability to target previously undruggable targets and have now received FDA approval in five instances for orphan or uncommon diseases. The current siRNA "-sirans" are directed towards hepatic molecular targets. Because they are not conventional drug formulae, their ultimate clinical success will require overcoming multiple barriers beyond their pharmacology. The minimal patient numbers leave fewer patients to bear the costs of R&D and manufacture; therefore, the cost of these drugs, questionable third-party reimbursement, and competition from other drug classes for the same low number of patients are impediments to patient access. The parenteral route of administration, as well as emerging safety restrictions, are also drawbacks to siRNA. With this review, we document currently approved siRNA drugs by condition, approval date, administration route and frequencies. We have estimated the available patient populations for siran therapies using the U.S. Medicaid and Medicare populations and sought to identify the frequency with which large Medicaid formularies list siRNA drugs. Current comparative costs between the siRNA drugs and alternatives have been presented, and the review summarizes current adverse events as reported to the FDA's Adverse Event Reporting System. Our review and data indicate that sirans are extremely expensive and seldom recognized in posted Medicaid formularies. However, alternative treatments for these conditions are no less costly, usually do not have significantly different adverse events, and are often less convenient for the patient. |
|---|
| ジャーナル名 | Pharmacy (Basel, Switzerland) |
|---|
| 投稿日 | 2024/4/26 |
|---|
| 投稿者 | Sehgal, Inder; Eells, Kevin; Hudson, Imani |
|---|
| 組織名 | College of Medicine, Rocky Vista University, Ivins, UT 84738, USA.;College of Medicine, Rocky Vista University, Parker, CO 80112, USA.;College of Pharmacy and Pharmaceutical Sciences, Florida A&M University,;Tallahassee, FL 32307, USA. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/38668084/ |
|---|
